Roberto Quarta - Smith Nephew Non-Executive Independent Chairman of the Board

<div class='circular--portrait' style='background:#FCD202;color: white;font-size:3em;padding-top: 40px;;'>SNN</div>
SNNUF -- USA Stock  

USD 24.30  0.20  0.83%

Mr. Roberto Quarta is NonExecutive Independent Chairman of the Board of Smith Nephew PLC., effective April 10, 2014. He joined the Board in December 2013 and appointed Chair following election by shareholders at the 2014 Annual General Meeting. He was also appointed Chair of the Nomination Governance Committee and a Member of the Remuneration Committee on that day. Career and experience Roberto is a graduate and a former Trustee of the College of the Holy Cross, Worcester, US. He started his career as a manager trainee at David Gessner Ltd, before moving on to Worcester Controls Corporationrationration and then BTR plc, where he was a divisional Chief Executive. Between 1985 and 1989 he was Executive VP of Hitchiner Manufacturing Co., Inc. He returned to BTR plc in 1989 as Divisional Chief Executive, where he was appointed to the main board. From here he moved to BBA Aviation plc, as CEO and then as Chair, until 2007. He has held several board positions, including NonExecutive Director of Powergen plc, Equant N.V., BAE Systems plc and Foster Wheeler AG. His previous Chairmanships include Italtel SpA, Rexel S.A., IMI plc and SPIE SA. He is currently Chair of WPP plc. He is a partner at Clayton Dubilier Rice and a former member of the Investment Committee of Fondo Strategico Italiano S.p.A. Skills and competencies Robertos career in private equity brings valuable experience to Smith Nephew, particularly when evaluating acquisitions and new business opportunities. He has an indepth understanding of differing global governance requirements having served as a director and chairman of a number of UK and international companies. Since his appointment as Chair in April 2014, he has conducted a comprehensive review into the composition of the Board and its Committees, and conducted the search for new NonExecutive Directors.
Age: 67  Chairman Since 2014      
44 19 2347 7100  http://www.smith-nephew.com

Management Efficiency

The company has return on total asset (ROA) of 7.62 % which means that it generated profit of $7.62 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 14.55 % meaning that it generated $14.55 on every $100 dollars invested by stockholders.
The company has accumulated 2.18 B in total debt with debt to equity ratio (D/E) of 44.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Smith Nephew Plc has Current Ratio of 1.96 which is within standard range for the sector.

Similar Executives

Found 2 records


William HooverGn Store Nord ADR
Per WoldOlsenGn Store Nord ADR

Company Summary

Smith Nephew plc develops, manufactures, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 16000 people.Smith Nephew Plc O [SNNUF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Smith Nephew Plc Leadership Team

Namal Nawana, CEO, Executive DirectorView
Michael Friedman, Non-Executive Independent DirectorView
Diogo MoreiraRato, President - Europe and CanadaView
Skip Kiil, President - OrthopedicsView
Erik Engstrom, Non-Executive DirectorView
Matthew Stober, President - Global OperationsView
Marc Owen, Non-Executive DirectorView
Rodrigo Bianchi, President IRAMEAView
Brian Larcombe, Senior Independent Non-Executive DirectorView
Elga Lohler, Chief Human Resource OfficerView
Gunthorp Oie, IR Contact OfficerView
Roland Diggelmann, Non-Executive DirectorView
Helen Maye, Chief Human Resources OfficerView
Vinita Bali, Non-Executive DirectorView
Simon Fraser, President - Advanced Wound ManagementView
Massimiliano Colella, President Europe - Middle East and AfricaView
Olivier Bohuon, CEO, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination and Governance CommitteeView
Graham Baker, CFO, Executive DirectorView
Cathy ORourke, Chief Legal and Compliance OfficerView
Roberto Quarta, Non-Executive Independent Chairman of the BoardView
Cyrille Petit, Chief Corporate Development OfficerView
Julie Brown, CFO, Director and Member of Disclosures CommitteeView
Glenn Warner, President - Advanced Wound ManagementView
Robin Freestone, Non-Executive DirectorView
Virginia Bottomley, Non-Executive Independent DirectorView
Phil Cowdy, Executive Vice President of Business Development & Corporate AffairsView
Angie Risley, Non-Executive DirectorView
Mark Gladwell, President - Global OperationsView
Vasant Padmanabhan, President - Research & DevelopmentView
Michael Frazzette, President - Advanced Surgical DevicesView
Joseph Papa, Non-Executive Independent DirectorView
Ingeborg Oie, VP, Investor RelationsView
Susan Swabey, Company SecretaryView
Melissa Guerdan, Chief Quality and Regulatory Affairs OfficerView
Gordon Howe, President of Global OperationsView
John Campo, Chief Legal OfficerView
Brad Cannon, President Europe and CanadaView
Ian Barlow, Non-Executive Independent DirectorView
Catheryn ORourke, Chief Legal OfficerView

Stock Performance Indicators

Did you try this?

Run Bollinger Bands Now


Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Module

Currently Active Assets on Macroaxis

Purchased one share of
1 hour ago
Traded for 116.67
Purchased few shares of
1 hour ago
Traded for 58.5
Purchased few shares of
1 hour ago
Traded for 66.38
Purchased few shares of
1 hour ago
Traded for 150.13
Purchased few shares of
1 hour ago
Traded for 48.82
Additionally take a look at World Market Map. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.